was ich zu sagen habe? das caly immer noch die gleichen probleme hat, wie vor einem halben jahr. die zukunft mit den tests ist auf keinen fall so rosig zu sehen, dass diese den markt abräumen werden.
ach kade, hier ist dein 8-k-filing, allerdings in etwas anderer form als sonst:
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.
(a) Effective January 14, 2005, Calypte Biomedical Corporation (the "Company")
issued an unsecured $2 million promissory note (the "Note") to Marr Technologies
BV, the Company's largest stockholder. The Note was funded on January 18, 2005.
The Note bears interest at a rate of 7% per annum and is payable in full no
later than March 31, 2005 (the "Maturity Date"). In the event the Note is not
paid in full by the Maturity Date, the unpaid principal and interest will
continue to accrue interest at a rate of 9% per annum thereafter.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: Pleasanton, California
January 18, 2005
Calypte Biomedical Corporation
By: /s/ Richard D. Brounstein
-------------------------------------------
Richard D. Brounstein
Executive Vice President and
Chief Financial Officer
die zinsen müssen bis 31.03 bezahlt sein, sonst steigt der zinssatz. so einfach bekommt caly die kohle nicht geschenkt.